{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T00:21:40Z","timestamp":1793924500562,"version":"4.8.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":2892,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1038\/sj.jid.5701033","type":"journal-article","created":{"date-parts":[[2007,9,6]],"date-time":"2007-09-06T07:53:10Z","timestamp":1189065190000},"page":"35-44","source":"Crossref","is-referenced-by-count":862,"title":["Stevens\u2013Johnson Syndrome and Toxic Epidermal Necrolysis: Assessment of Medication Risks with Emphasis on Recently Marketed Drugs. The EuroSCAR-Study"],"prefix":"10.1016","volume":"128","author":[{"given":"Maja","family":"Mockenhaupt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecile","family":"Viboud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariane","family":"Dunant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Naldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sima","family":"Halevy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Nico Bouwes","family":"Bavinck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Sidoroff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Schneck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Claude","family":"Roujeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Flahault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/sj.jid.5701033_bb0010","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1001\/archderm.138.8.1019","article-title":"Correlations between clinical patterns and causes of erythema multiforme majus, Stevens\u2013Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study","volume":"138","author":"Auquier-Dunant","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1038\/sj.jid.5701033_bb0015","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1097\/00002030-200009290-00012","article-title":"Prevention of Nevirapine-associated exanthema using slow dose escalation and\/or corticosteroids","volume":"14","author":"Barreiro","year":"2000","journal-title":"AIDS"},{"key":"10.1038\/sj.jid.5701033_bb0020","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","article-title":"A clinical classification of cases of toxic epidermal necrolysis, Stevens\u2013Johnson syndrome and erythema multiforme","volume":"129","author":"Bastuji-Garin","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1038\/sj.jid.5701033_bb0025","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(97)11369-1","article-title":"Toxic epidermal necrolysis","volume":"351","author":"Becker","year":"1998","journal-title":"Lancet"},{"key":"10.1038\/sj.jid.5701033_bb0030","first-page":"441","article-title":"Lyell syndrome or toxic epidermal necrolysis and Stevens\u2013Johnson syndrome after treatment with fluoxetine","volume":"47","author":"Bodokh","year":"1992","journal-title":"Therapie"},{"key":"10.1038\/sj.jid.5701033_bb0035","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/S0140-6736(00)04972-2","article-title":"Variation in antibiotic use in the European Union","volume":"357","author":"Cars","year":"2001","journal-title":"Lancet"},{"key":"10.1038\/sj.jid.5701033_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00002030-200109280-00014","article-title":"Nevirapine and the risk of Stevens\u2013Johnson syndrome or toxic epidermal necrolysis: preliminary results of a case-control study","volume":"15","author":"Fagot","year":"2001","journal-title":"AIDS"},{"key":"10.1038\/sj.jid.5701033_bb0045","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1159\/000074120","article-title":"Erythema multiforme-like drug eruption with oral involvement after intake of leflunomide","volume":"207","author":"Fischer","year":"2003","journal-title":"Dermatology"},{"key":"10.1038\/sj.jid.5701033_bb0050","first-page":"1213","article-title":"Toxic epidermal necrolysis due to administration of celecoxib (Celebrex)","volume":"96","author":"Friedman","year":"2003","journal-title":"South Med J"},{"key":"10.1038\/sj.jid.5701033_bb0055","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1159\/000247338","article-title":"Cutaneous reactions to analgesic-antipyretics and non-steroidal anti-inflammatory drugs. Analysis of reports to the spontaneous reporting system of the Gruppo Italiano Studi Epidemiologici in Dermatologia","volume":"186","author":"GISED","year":"1993","journal-title":"Dermatology"},{"key":"10.1038\/sj.jid.5701033_bb0060","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/0140-6736(91)90112-3","article-title":"Stevens\u2013Johnson syndrome after fluconazole","volume":"338","author":"Gussenhoven","year":"1991","journal-title":"Lancet"},{"key":"10.1038\/sj.jid.5701033_bb0065","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1080\/000155599750010472","article-title":"Stevens\u2013Johnson syndrome after sertraline","volume":"79","author":"Jan","year":"1999","journal-title":"Acta Derm Venereol"},{"key":"10.1038\/sj.jid.5701033_bb0070","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/0895-4356(95)00004-N","article-title":"An international collaborative case\u2013control study of severe cutaneous adverse reactions (SCAR). Design and methods","volume":"48","author":"Kelly","year":"1995","journal-title":"J Clin Epidemiol"},{"key":"10.1038\/sj.jid.5701033_bb0075","first-page":"2234","article-title":"The risk of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis associated with non-steroidal antiinflammatory drugs: a multinational perspective","volume":"30","author":"Mockenhaupt","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1038\/sj.jid.5701033_bb0080","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1212\/01.WNL.0000156354.20227.F0","article-title":"Risk of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in new users of anti-epileptics","volume":"64","author":"Mockenhaupt","year":"2005","journal-title":"Neurology"},{"key":"10.1038\/sj.jid.5701033_bb0085","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1001\/jama.279.20.1613-a","article-title":"Toxic epidermal necrolysis from atorvastatin","volume":"279","author":"Pfeiffer","year":"1998","journal-title":"JAMA"},{"key":"10.1038\/sj.jid.5701033_bb0090","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1056\/NEJM199411103311906","article-title":"Severe cutaneous adverse reactions to drugs","volume":"331","author":"Roujeau","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1038\/sj.jid.5701033_bb0095","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1056\/NEJM199512143332404","article-title":"Medication use and the risk of Stevens\u2013Johnson syndrome or toxic epidermal necrolysis","volume":"333","author":"Roujeau","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1038\/sj.jid.5701033_bb0100","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1016\/S0140-6736(98)05418-X","article-title":"Risk of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis during first weeks of anti-epileptic therapy: a case\u2013control study","volume":"353","author":"Rzany","year":"1999","journal-title":"Lancet"},{"key":"10.1038\/sj.jid.5701033_bb0105","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/0895-4356(96)00035-2","article-title":"Epidemiology of erythema exsudativum multiforme majus (EEMM), Stevens\u2013Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in Germany (1990\u20131992). Structure and results of a population based registry","volume":"49","author":"Rzany","year":"1996","journal-title":"J Clin Epidemiol"},{"key":"10.1038\/sj.jid.5701033_bb0110","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0190-9622(08)81961-5","article-title":"Stevens\u2013Johnson syndrome after terbinafine therapy","volume":"30","author":"Rzany","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.1038\/sj.jid.5701033_bb0115","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0140-6736(05)66227-7","article-title":"Lamotrigine and toxic epidermal necrolysis","volume":"348","author":"Sachs","year":"1996","journal-title":"Lancet"},{"key":"10.1038\/sj.jid.5701033_bb0120","series-title":"Epidemiological Evaluation of Drugs","article-title":"Case control surveillance of serious illnesses attributable to ambulatory use of drugs","author":"Slone","year":"1977"},{"key":"10.1038\/sj.jid.5701033_bb0125","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0140-6736(98)24008-6","article-title":"Nevirapine-associated Stevens\u2013Johnson syndrome","volume":"351","author":"Warren","year":"1998","journal-title":"Lancet"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15336149?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15336149?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T17:26:26Z","timestamp":1556817986000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15336149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S0022202X15336149"],"URL":"https:\/\/doi.org\/10.1038\/sj.jid.5701033","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}